Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Saita

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
BJUI Compass|April 27, 2022
Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label studyRodolfo Hurle, Paolo Casale, Emanuela Morenghi, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 11, 2014
Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective studyTommaso Castelli, Giorgio Ivan Russo, Vincenzo Favilla, et al.
European Urology Open Science|August 2, 2021
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center ExperienceMarco Paciotti, Paolo Casale, Piergiuseppe Colombo, et al.
World Journal of Urology|February 5, 2017
Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone diseaseHelene Jung, Sero Andonian, Dean Assimos, et al.
World Journal of Urology|October 5, 2022
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES-UTUC registryJoyce Baard, Shahrokh F Shariat, Morgan Roupret, et al.
World Journal of Urology|April 3, 2021
Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experienceNicola Frego, Alberto Saita, Paolo Casale, et al.
European Urology Oncology|June 1, 2021
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) ExperienceRoberto Contieri, Marco Paciotti, Giovanni Lughezzani, et al.
European Urology Focus|November 11, 2018
Early Catheter Removal After Robot-assisted Radical Prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study)Giuliana Lista, Giovanni Lughezzani, Nicolò Maria Buffi, et al.
Urologic Oncology|June 29, 2021
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysisPier Paolo Avolio, Giovanni Lughezzani, Marco Paciotti, et al.
European Urology Focus|October 18, 2020
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective StudyGiovanni Lughezzani, Davide Maffei, Alberto Saita, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
BJUI Compass|April 27, 2022
Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label studyRodolfo Hurle, Paolo Casale, Emanuela Morenghi, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 11, 2014
Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective studyTommaso Castelli, Giorgio Ivan Russo, Vincenzo Favilla, et al.
European Urology Open Science|August 2, 2021
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center ExperienceMarco Paciotti, Paolo Casale, Piergiuseppe Colombo, et al.
World Journal of Urology|February 5, 2017
Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone diseaseHelene Jung, Sero Andonian, Dean Assimos, et al.
World Journal of Urology|October 5, 2022
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES-UTUC registryJoyce Baard, Shahrokh F Shariat, Morgan Roupret, et al.
World Journal of Urology|April 3, 2021
Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experienceNicola Frego, Alberto Saita, Paolo Casale, et al.
European Urology Oncology|June 1, 2021
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) ExperienceRoberto Contieri, Marco Paciotti, Giovanni Lughezzani, et al.
European Urology Focus|November 11, 2018
Early Catheter Removal After Robot-assisted Radical Prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study)Giuliana Lista, Giovanni Lughezzani, Nicolò Maria Buffi, et al.
Urologic Oncology|June 29, 2021
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysisPier Paolo Avolio, Giovanni Lughezzani, Marco Paciotti, et al.
European Urology Focus|October 18, 2020
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective StudyGiovanni Lughezzani, Davide Maffei, Alberto Saita, et al.
Pageof 10